軍團(tuán)菌尿抗原測(cè)試紙 軍團(tuán)菌尿抗原測(cè)試紙

廣州健侖生物科技?有限公司 

本司長(zhǎng)期供應(yīng)軍團(tuán)菌試劑盒 其主要品牌包括美國(guó)NovaBios、廣州健侖、廣州創(chuàng)侖等進(jìn)口產(chǎn)品，國(guó)產(chǎn)產(chǎn)品，試劑盒的實(shí)驗(yàn)方法是膠體金方法。

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢

介紹

以急性發(fā)熱性呼吸道癥狀為特征的退伍軍人癥是由吸入含有嗜肺軍團(tuán)菌的霧化水引起的。嗜肺軍團(tuán)菌血清組1zui常從患者中分離（1,2）。
IMMUNOCATCHTM軍團(tuán)菌（Legionella）是一種側(cè)流免疫層析法，可通過快速可靠地檢測(cè)尿樣中的抗原，對(duì)嗜肺軍團(tuán)菌血清型1感染進(jìn)行早期診斷。

原理

本產(chǎn)品是一種試劑盒，設(shè)計(jì)用于免疫層析法檢測(cè)尿樣中嗜肺軍團(tuán)菌血清型1 LPS抗原。
當(dāng)樣品通過毛細(xì)作用遷移通過結(jié)合墊時(shí)，樣品中的軍團(tuán)菌抗原與綴合至膠體顆粒的抗軍團(tuán)菌抗體結(jié)合形成抗原 - 抗體復(fù)合物?？乖?- 抗體復(fù)合物在試紙條上遷移，與固定在膜上的抗軍團(tuán)菌抗體特異性結(jié)合而產(chǎn)生紅線。然后通過肉眼觀察紅線的存在來確定軍團(tuán)菌抗原的存在。
此外，抗-Legionella抗體偶聯(lián)的膠體金在反應(yīng)中不被消耗，與固定在對(duì)照線上的抗免疫球蛋白抗體結(jié)合產(chǎn)生紅線，表明在測(cè)試條上的反應(yīng)是成功的。

【包裝規(guī)格】20T/盒

【檢測(cè)方法】

1）從鋁袋中取出所需數(shù)量的磁帶，并將它們放在水平面上。

2）使用定量移液器慢慢地吸取90μL或更多的樣品。 通過一次移液操作，將全部樣品滴入盒子的樣品位置。 滴下后，剩余的標(biāo)本留在吸管內(nèi)。

3）在室溫（15-30°C）下將盒子放置15分鐘，

4）檢查盒子評(píng)估地點(diǎn)是否有線（標(biāo)有“C”和“T”）。

結(jié)果

應(yīng)該在反應(yīng)開始15分鐘后及時(shí)進(jìn)行評(píng)估。 檢查評(píng)估地點(diǎn)，并通過下面描述的紅線來評(píng)估結(jié)果。
1）正面：紅色控制線和測(cè)試線均在評(píng)估現(xiàn)場(chǎng)。 當(dāng)兩條線在反應(yīng)時(shí)間結(jié)束之前出現(xiàn)時(shí)結(jié)果是肯定的。
2）否定的：評(píng)估地點(diǎn)只有一條紅色的控制線。
3）無效：無論控制線是否存在，無論是否存在測(cè)試線，測(cè)試均無效。

治療犬細(xì)菌性腹瀉時(shí)，濫用抗生素可能會(huì)引起耐藥株及犬自身腸道菌群失調(diào)，從而加重腹瀉癥狀。
目前醫(yī)學(xué)上抗生素的應(yīng)用存在諸多問題：耐藥菌株急劇增加，抗生素殘留污染環(huán)境，細(xì)菌性疾病在動(dòng)物之間以及動(dòng)物與人之間相互傳播加劇。由于在動(dòng)物飼料添加劑中，長(zhǎng)期小劑量抗生素的使用，會(huì)加重耐藥菌的傳播和擴(kuò)散，犬腸道細(xì)菌對(duì)抗生素的耐受性增加，使犬的腸道細(xì)菌病防治難度不斷增大。
三、微生態(tài)制劑對(duì)防治犬細(xì)菌性腹瀉具有重要作用
犬微生態(tài)制劑作為一種無毒、*、無殘留的綠色生物獸藥和犬用添加劑，在對(duì)寵物犬疾病的治療和預(yù)防保健中發(fā)揮越來越重要的作用。在國(guó)外，微生態(tài)制劑已經(jīng)被用于不同動(dòng)物的一系列疾病的治療和預(yù)防。微生態(tài)制劑已大量用作獸醫(yī)的治療藥物，特別是用于寵物犬和貓等，在對(duì)寵物犬疾病的治療和預(yù)防中將會(huì)廣泛使用。在國(guó)內(nèi)，犬用微生態(tài)制劑還在起步階段。我國(guó)是一個(gè)養(yǎng)犬大國(guó)，綠色犬生物獸藥和食品添加劑的需求量很大，市場(chǎng)前景極為廣闊。犬用微生態(tài)制劑的開發(fā)與應(yīng)用不僅會(huì)給飼料工業(yè)和生物獸藥帶來可觀的經(jīng)濟(jì)效益，同時(shí)對(duì)我國(guó)生態(tài)細(xì)菌和環(huán)境治理也將產(chǎn)生深遠(yuǎn)影響。
但微生態(tài)制劑現(xiàn)在還存在著一 些問題：對(duì)犬用微生態(tài)制劑的作用機(jī)理研究不夠深入，微生態(tài)制品質(zhì)量標(biāo)準(zhǔn)難以統(tǒng)一，益生菌在加工、儲(chǔ)運(yùn)和使用過程中易失活，某些益生菌在腸道定植時(shí)間短等。
日前，廣東藥學(xué)院公共衛(wèi)生學(xué)院副教授姚振江在學(xué)術(shù)期刊《科學(xué)報(bào)告》上發(fā)布的研究顯示，其研究團(tuán)隊(duì)在廣州地鐵7條線路上采集了320個(gè)乘客常觸碰位置的樣本，檢測(cè)出2.5%的樣本含有超級(jí)細(xì)菌——耐甲氧西林金黃色葡萄球菌(MRSA)。
這種細(xì)菌對(duì)抗生素有較強(qiáng)抗藥性，一旦感染可致死亡。但醫(yī)藥專家稱，耐藥細(xì)菌雖然危險(xiǎn)，但正常人感染率極低，無需恐慌。
抽檢7線路，檢出率2.5%由于在動(dòng)物飼料添加劑中，長(zhǎng)期小劑量抗生素的使用，會(huì)加重耐藥菌的傳播和擴(kuò)散，犬腸道細(xì)菌對(duì)抗生素的耐受性增加，使犬的腸道細(xì)菌病防治難度不斷增大。

想了解更多的韓國(guó)SD產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】    楊永漢 

【】
【騰訊 】
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室

【企業(yè)文化宣傳】

Treatment of bacterial diarrhea in dogs, the abuse of antibiotics may cause resistance strains and the dog's own intestinal flora, thereby aggravating diarrhea.
At present, there are many problems in the application of antibiotics in medicine, such as the rapid increase of drug-resistant strains, the pollution of antibiotic residues and the spread of bacterial diseases among animals and between animals. As animal feed additives, the use of long-term low-dose antibiotics will increase the spread and spread of drug-resistant bacteria, dogs and gut bacteria increased resistance to antibiotics, the dog's intestinal bacterial disease prevention and control increasingly difficult.
Third, probiotics have an important role in the prevention and treatment of bacterial diarrhea in dogs
As a non-toxic, non-toxic, non-residual green veterinary drugs and dog additives, canine probiotics play an increasingly important role in the treatment and prevention of pet dog diseases. Abroad, probiotics have been used in the treatment and prevention of a range of diseases in different animals. Micro-ecological agents have been widely used as veterinary therapeutic drugs, especially for pet dogs and cats and the like, and will be widely used in the treatment and prevention of dog diseases. In China, dog probiotics are still in their infancy. China is a big country in dog breeding. The demand of green dog biological veterinary drugs and food additives is very big, and the market prospect is extremely broad. The development and application of canned probiotics will not only bring considerable economic benefits to the feed industry and biological veterinary drugs, but also have a profound impact on ecological bacteria and environmental management in China.
However, there are still some problems in probiotics: the mechanism of action of probiotics in dogs is not deep enough, the quality standards of probiotics are difficult to unify, the probiotics are easy to inactivate during processing, storage and transportation, and some probiotics Bacteria in the intestinal colonization time is short and so on.
A few days ago, Yao Zhenjiang, an associate professor of the School of Public Health at Guangdong Pharmaceutical University, published a research report in the international academic journal Science Report. His research team collected 320 samples of frequently touched locations on 7 lines of the Guangzhou Metro and detected 2.5 % Of the samples contain the super bacteria - methicillin-resistant Staphylococcus aureus (MRSA).
This bacterium is highly resistant to antibiotics and can cause death if infected. However, medical experts said that drug-resistant bacteria are dangerous, but the rate of normal people is extremely low, without panic.
Sampling 7 lines, the detection rate of 2.5% Since the use of long-term low-dose antibiotics in animal feed additives will increase the spread and spread of drug-resistant bacteria, dogs and canine bacterial tolerance to antibiotics increased, so that the dog's intestine Bacterial disease prevention and control increasing difficulty.